Bio-Rad Laboratories (BIO) Treasury Shares (2012 - 2026)

Bio-Rad Laboratories (BIO) has 15 years of Treasury Shares data on file, last reported at $1.1 billion in Q1 2026.

• On a quarterly basis, Treasury Shares rose 21.47% year-over-year to $1.1 billion in Q1 2026; TTM through Mar 2026 was $1.1 billion, a 21.47% increase from a year earlier, with the FY2025 full-year figure at $1.0 billion, up 30.76% from the prior year.
• Treasury Shares for Q1 2026 stood at $1.1 billion, up from $1.0 billion in the prior quarter.
• Over the last five years, Treasury Shares for BIO reached as high as $4.1 million in Q2 2025 and fell as low as $279544.0 in Q1 2022.
• Historically, Treasury Shares has averaged $2.0 million across 5 years, with a median of $2.3 million in 2024.
• On a YoY basis, Treasury Shares climbed as much as 147.99% in 2022 and fell as far as 29.1% in 2022.
• Year by year, Treasury Shares stood at $263.6 million in 2022, then surged by 139.96% to $632.5 million in 2023, then advanced by 22.07% to $772.1 million in 2024, then soared by 30.76% to $1.0 billion in 2025, then gained by 4.3% to $1.1 billion in 2026.
• Per Business Quant data, the three most recent Treasury Shares figures were $1.1 billion in Q1 2026, $1.0 billion in Q4 2025, and $1.0 billion in Q3 2025.